Samuel Kareff, MD, MPH Chief Fellow Hematology/Medical OncologyUniversity of Miami, Sylvester Comprehensive Cancer Center, Jackson Memorial Hospital

Samuel A. Kareff, MD, MPH, is a Chief Fellow of the Hematology/Medical Oncology training program at the University of Miami Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital. As a South Florida native, Dr. Kareff has been serving and researching his home patient population since graduating from the University of Miller School of Medicine’s dual MD/MPH program in 2018. He plans to specialize in the care of solid tumors, namely, thoracic oncology, upon completion of his fellowship.

Priscila Barreto Coelho, MD Chief Fellow Hematology/Medical OncologyUniversity of Miami, Sylvester Comprehensive Cancer Center, Jackson Memorial Hospital

Priscila Barreto Coelho, MD, is a Hematology and Medical Oncology fellow at the Jackson Memorial Hospital and Sylvester Comprehensive Cancer Center (SCCC) at the University of Miami Health System. Her focus on research and training is breast cancer, especially the etiology of breast cancer in genetically high-risk germline mutation carriers, the disparities involved in this disease, and the use of targeted therapies in cancer treatment. She is a member of the women’s cancer research working group in the African Caribbean Cancer Consortium (AC3) and the Sarcoma Interest Group (SIG) at the University of Miami. She has been involved in research demonstrating the disparities in the presentation and outcomes of breast cancer in the population of South Florida and the Caribbean and the use of targeted therapies to treat specific types of sarcomas. She is involved in research that focuses on the study of breast cancers in women from South Florida and the Caribbean, evaluating the impact of deleterious variants in genes that characterize the hereditary cancer syndromes and the impact of immigration and lifestyle changes on the development and outcomes of breast cancer in Black women for which she was granted a 2023 ASCO YIA.

JOIN HERE!

Objectives:

1.Demonstrate the value of glioma classification
2.Explain the role of molecular characterization in glioma.
3.Assess the role of novel targeted therapeutics for glioma.
4.Analyze a specific case with the healthcare system, identifying critical factors that led to complications and exploring preventive measures that could have been implemented.
5.Delve into current guidelines within the field of oncology pertaining to the reactivations of tuberculosis in patients undergoing chemotherapy, with a focus on understanding protocols, preventative measures, and management strategies.
6.Create actionable strategies for enhancing the care of oncologic patients in regions with high prevalence of tuberculosis by synthesizing insights from current practices and exploring innovative approaches to improve patient outcomes and mitigate the risk of tuberculosis reactivation.

FACULTY DISCLOSURES:

Dr. Kareff has indicated that he has relevant financial relationship with commercial interests.

Independent contractor: Pathway Medical, Inc.

Royalties or patent beneficiary: Academy for Continued Healthcare Education; Integrity Continuing Education; Healthcare Course, Inc.; Precisca; Research to Practice

Speaker: i3 Health

Dr. Barreto has indicated that she has no relevant financial relationship with commercial interests.

Dr. Lekakis has indicated that he has no relevant financial relationships with commercial interests.

All the relevant financial relationships for these individuals have been mitigated.

TARGET AUDIENCE:
Faculty, Primary Care Physicians, APRNs, PharmD

ACCREDITATION:
The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION:
The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.